BK1304 Secondary Listings on HKEX
- 602.858
- -2.907-0.48%
Kanzhun's 2023 Profit, Revenue Rise
Kanzhun's (HKG:2076) attributable profit surged to 1.10 billion yuan, or 1.22 yuan per share, in 2023 from 107.2 million yuan, or 0.12 yuan per share, in 2022, according to the company's annual report
YUM CHINA To Go Ex-Dividend On May 27th, 2024 With 1.25214 HKD Dividend Per Share
May 1st - $YUM CHINA(09987.HK)$ is trading ex-dividend on May 27th, 2024. Shareholders of record on May 28th, 2024 will receive 1.25214 HKD dividend per share on June 18th, 2024. The ex-dividend d
Here's Why Yum China Stock Dropped Today
Does MINISO Group Holding Limited (MNSO) Have the Potential to Rally 27.87% as Wall Street Analysts Expect?
Does HUTCHMED (HCM) Have the Potential to Rally 38.13% as Wall Street Analysts Expect?
Yum China's Profit Down in Q1
Yum China (HKG:9987) recorded a 1% decline in net income for the quarter ended March 31 to $287 million from $289 million during the year-ago period, according to a Tuesday filing on the Hong Kong. Ea
Oppenheimer Reaffirms Their Hold Rating on Yum China Holdings (YUMC)
Jinshan Cloud (KC.US, 03896.HK) released its 2023 annual report and ESG report first disclosed three carbon emissions data
Jinshan Cloud released its 2023 annual report and ESG report, and its high-quality sustainable development strategy has achieved remarkable results.
金山雲：2023 年度報告
JPMorgan Initiates MINISO Group Holding With Overweight Rating, $30 Price Target
MINISO Group Holding (MNSO) has an average rating of buy and price targets ranging from $25.32 to $33.22, according to analysts polled by Capital IQ. Price: 23.29, Change: +0.15, Percent Change: +0.65
Shell-W (02423) spent about $2 million to buy back 389,600 shares on April 29
Shell-W (02423) issued an announcement to spend about 2 million US dollars to repurchase shares 3 on April 29, 2024...
BeiGene PD-1 inhibitor Baizean approved 13th application for indication in China
China National Drug Administration (NMPA) approves Baize'an (tirelizumab) as a new indication for gastric cancer, Beijing, April 30, 2024/4/2024/PRNewswire/ -- BeiGene (NASDAQ: BGNE; Hong Kong Stock Exchange code: 06160; Shanghai Stock Exchange code: 688235), a global cancer treatment innovation company, announced today that its PD-1 inhibitor baizean (tirelizumab) has been officially approved by China's National Drug Administration (China Drug Administration) in combination with fluorouracil and platinum chemotherapeutics For advanced local use, unresectable or metastatic stomach or stomach eating
Yum China Shares Are Trading Lower After the Company Reported Mixed Q1 Financial Results.
Yum China Shares Are Trading Lower After the Company Reported Mixed Q1 Financial Results.
Trip.com Group Filed 2023 Annual Report on Form 20-F
SINGAPORE, April 30, 2024 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading one-stop travel service provider of accommodation reservation
Yum China (09987.HK) spent HK$4.69 million to buy back 15,000 shares on April 29th
Gelonghui, April 30, 丨 Yum China (09987.HK) announced that it spent HK$4.69 million to buy back 15,000 shares on April 29.
Earnings Call: Yum China Posts Solid Q1 With Growth and Expansion Plans
Yum China Holdings, Inc. (NYSE:YUMC) has reported a robust performance for the first quarter of 2024, with significant growth in system sales and an aggressive expansion strategy.
Beishui Trends | Beishui Trading's net purchases of 3.249 billion domestic bank stocks and domestic housing stocks are now divided, and China Mobile (00941) has increased its positions
On April 30, in the Hong Kong stock market, Beishui made a net purchase of HK$3,249 million, of which the Hong Kong Stock Connect (Shanghai) transaction made a net purchase of HK$2.77 billion and the Hong Kong Stock Connect (Shenzhen) transaction made a net purchase of HK$479 million.
Core financial indicators continue to grow, and Yum China (09987) is becoming more and more certain
If the number of stores that continue to expand or the business growth of the same stores leverages more profit space for Yum China, then a diversified business layout is an important cornerstone for Yum China to achieve steady growth.
Alibaba-SW (09988.HK): Results will be announced on May 14
Gelonghui, April 30 | Alibaba-SW (09988.HK) issued an announcement. The board of directors will hold a board meeting on May 13, 2024, and will approve proposals such as unaudited results and performance announcements for the three months ended March 31, 2024 and the financial year. Results will be announced on May 14, 2024.
董事會會議召開日期